EVO ICL has a strong and well-documented safety profile. The lens is made from Collamer, a biocompatible material that has been used in implantable eye surgery for over two decades and includes built-in UV protection. In FDA clinical trials, 99% of patients reported they would choose the procedure again. The central-port design of the EVO model eliminates the need for a pre-operative iridotomy and reduces the risk of elevated eye pressure seen with earlier ICL versions. The lens does not contact the natural lens and does not cause cataracts in appropriately selected patients. With more than two million EVO lenses implanted worldwide, the long-term safety record is extensive. At Florida Eye Custom Vision, Drs. Chokshi and Hasan review every patient’s complete ocular history before recommending EVO ICL surgery.
— Dr. Amit Chokshi, MD & Dr. S. Akbar Hasan, MD, Florida Eye Custom Vision